BackgroundTitanium dioxide (TiO2) is a brightening compound used as an additive in food and pharmaceuticals. TiO2 safety has been debated since evidence of carcinogenicity and genotoxicity emerged. While TiO2 is provisionally used as food additive by North America, it is banned by European Union (EU) countries and Saudi Arabia. There are no international regulations regarding TiO2 as an additive in medicinal, herbal or health products. In this study, the primary objective is to identify the percentage of herbal and health products containing TiO2 among all Saudi Food and Drugs Authority (SFDA) newly registered products during the period from 2018 to 2022. A secondary objective is to describe products containing TiO2 according to product type, pharmaceutical form, registration year and manufacturing country. MethodsThis study is a retrospective secondary data analysis using data derived from SFDA electronic products registration records (EURS) and drug management system (DMS). Descriptive analysis is conducted to describe the percentage of herbal and health products containing TiO2 among all SFDA- newly registered products during the period from 1st, Jan 2018 to 31st, Dec 2022. ResultsOne third [N:115, (31%)] of herbal and health products contain TiO2. Most TiO2-containing products were found in capsule pharmaceutical form [97 out of 115 (84%)], with significant statistical correlation (P=0.02). TiO2-containing products registration has peaked in 2020, then declined afterwards. Most products are provided by USA manufacturing companies, Spain and local companies, collectively. ConclusionTitanium dioxide is used as an additive in food and pharmaceutical products including health and herbal products. It has been banned in food products by countries and provisionally used by other countries. Concerning pharmaceutical products, regulatory authorities and policy makers are in need of insights for any potential TiO2 restriction in these products. One third of newly registered herbal and health products contain TiO2, of which market availability may be affected in case of restrictive regulatory actions. USA and local manufacturing companies are leading contributors to TiO2-containing herbal and health products registered by SFDA. Exploring alternatives for TiO2 and TiO2-free products is needed.
Read full abstract